Clovis Oncology Inc EV/EBIT
Cos'è EV/EBIT di Clovis Oncology Inc?
EV/EBIT di Clovis Oncology Inc è N/A
Qual è la definizione di EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT di aziende nel Health Care settore su NASDAQ rispetto a Clovis Oncology Inc
Aziende con ev/ebit simili a Clovis Oncology Inc
- Novan Inc ha EV/EBIT di N/A
- Providence Resources P.l.c ha EV/EBIT di N/A
- Pioneer Power Solutions Inc ha EV/EBIT di N/A
- Apollo Gold ha EV/EBIT di N/A
- Electreon Wireless Ltd ha EV/EBIT di N/A
- Clover Leaf Capital Corp ha EV/EBIT di N/A
- Clovis Oncology Inc ha EV/EBIT di N/A
- Innate Pharma ha EV/EBIT di N/A
- Perimeter Medical Imaging AI ha EV/EBIT di N/A
- Pmv Pharmaceuticals Inc ha EV/EBIT di N/A
- Cluey Ltd ha EV/EBIT di N/A
- SPORTTOTAL AG ha EV/EBIT di N/A
- Christopher & Banks ha EV/EBIT di N/A